199730 — BioInfra Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual cashflow statement for BioInfra Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	4,191	6,234	6,237	2,002	-3,976
Depreciation
Amortisation
Non-Cash Items	-417	1,335	967	114	-1,053
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-544	-2,185	-757	-3,822	3,445
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	4,171	6,563	8,425	679	1,729
Capital Expenditures	-2,321	-14,425	-10,681	-3,698	-2,871
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-5.8	-479	10,560	-6,999	-2,700
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities	-2,327	-14,904	-121	-10,696	-5,571
Financing Cash Flow Items	—	—	-6.6	0	449
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	2,249	6,948	-6,723	13,349	-2,820
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4,093	-1,393	1,580	3,332	-6,661